.png?width=185&height=108&name=R%20(2).png)
.png?width=225&height=300&name=Untitled%20design%20(27).png)
Pr. Bas Bloem, MD, PhD
Neurologist & founder of the Radboudumc Center of Expertise for Parkinson's & Movement Disorders, Radboud University
“I strongly believe in the concept of neuroClues, but as a scientist, it must be rigorously validated. We are launching a large study in patients with parkinsonian symptoms where the diagnosis remains uncertain. If the study proves successful, I can envision widespread adoption among neurologists in the Netherlands.”
Dr. Thibault Warlop, MD, PhD
Neurologist, Chwapi
“The neuroClues® device provides access to highly precise data. Its main value lies in the differential diagnosis of parkinsonian syndromes. Atypical forms remain difficult to identify at an early stage. Information derived from eye movements can help distinguish between conditions that are clinically very similar.”
Pr. Antonella Boschi
Head of Clinic, Neuro-ophthalmology Department, Cliniques universitaires Saint-Luc
“Eyetracking allows the early diagnosis of neurological and ophthalmological diseases. neuroClues® is an easy-to-use tool that will allow the recording of eye movements of both adults and children in just a few minutes.”
.png?width=1000&height=666&name=Untitled%20design%20(12).png)
Differential diagnosis of atypical parkinsonian syndromes
Objective quantification of cerebellar syndrome
.png?width=2163&height=1413&name=Untitled%20design%20(16).png)
.png?width=1294&height=1269&name=Untitled%20design%20(18).png)
.png?width=2059&height=2053&name=Untitled%20design%20(19).png)
.png?width=1291&height=1163&name=Untitled%20design%20(24).png)
Our development is financed with the support of the Walloon Region and the European Innovation Council.
